Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Eos and collaborators identify novel genes involved in immune system regulation

Feb. 21, 2000

Production, synthesis and activity of new Xenova compounds for immunoinflammatory conditions

Feb. 17, 2000

Positive phase III trial results reported by Genelabs for lupus treatment

Feb. 16, 2000

Sulfonamide-based inhibitors of TNF-alpha production synthesized at Shionogi

Feb. 14, 2000

Major European introduction for Merck's COX-2 inhibitor

Feb. 14, 2000

p38 MAPK inhibitor assessed in rat adjuvant-induced arthritis

Feb. 14, 2000

German firm launches important new drug on the domestic market

Feb. 11, 2000

Sankyo presents new inhibitors of inflammatory cytokine production

Feb. 10, 2000

New cell adhesion inhibitors designed at Celltech

Feb. 10, 2000

Idun patents new dipeptide mimetics that inhibit ICE/ced-3 cysteine proteases

Feb. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...